Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-19

Clinical Trial Update: Post-market Study to Capture Information Regarding Performance of Lyric2 [NA]

View source ↗

Summary

A post-market study evaluating Lyric2 performance in individuals with hearing loss completed, with results posted on 2014-05-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Phonak AG, Switzerland | Conditions: Hearing Loss | NA | Status: COMPLETED | Results posted: 2014-05-19